Background {#Sec1}
==========

Juvenile polyposis is a gastrointestinal polyposis characterized by the development of numerous hamartomatous and nonneoplastic polyps \[[@CR1]\], with a prevalence of approximately one in 100,000--160,000 \[[@CR2]\]. The most frequently affected site is the colorectum (98%), followed by the stomach (14%), jejunum and ileum (6.5%), and duodenum (2.3%) \[[@CR3]\]. Juvenile polyposis limited to the stomach is very rare. Some patients have a family history of juvenile polyposis with an autosomal dominant pattern of inheritance, and *SMAD4* and *BMPR1A* have recently been identified as causative genes for juvenile polyposis \[[@CR4], [@CR5]\]. Furthermore, although juvenile polyposis is generally recognized as a benign lesion, it has been associated with a predisposition to gastrointestinal cancer in some cases \[[@CR6]--[@CR8]\]. We report a very rare case of a patient with non-familial juvenile polyposis restricted to the stomach and gastric cancers, who was treated by laparoscopy-assisted total gastrectomy.

Case presentation {#Sec2}
=================

A 63-year-old man was evaluated for anemia (hemoglobin 11.8 g/dl) and hypoalbuminemia (albumin 3.7 g/dl) in another hospital. He had been diagnosed with gastric polyposis 5 years ago. He underwent esophagogastroduodenoscopy, which showed multiple reddish polyps accompanied by bleeding and erosion throughout the stomach (Fig. [1a](#Fig1){ref-type="fig"}) and two elevated lesions with irregular margins in the anterior wall of the corpus (Fig. [1b](#Fig1){ref-type="fig"}) and lesser curvature of the angular region (Fig. [1c](#Fig1){ref-type="fig"}) of the stomach. Histopathological diagnosis of the two elevated lesions by biopsy showed well-differentiated adenocarcinomas. He was referred to our hospital for treatment of gastric polyposis with gastric cancers. He had no medical history except for gastric polyposis, no family history, and no physical findings such as skin pigmentation or abnormalities of the hair and nails. Blood biochemical tests were negative for tumor markers (carcinoembryonic antigen, 0.6 ng/ml; carbohydrate antigen 19--9, 6.7 U/ml). Computed tomography showed gastric wall thickening, but no lymphadenopathy or distant metastasis. Colonoscopy showed only a polyp in the transverse colon, with a histopathological diagnosis of adenoma. The clinical stage was T1a N0 M0 stage IA according to the Japanese Gastric Cancer Association staging system (14th edition). He underwent laparoscopy-assisted total gastrectomy with D1+ dissection and Roux-en-Y esophagojejunostomy. The resected specimen revealed numerous small and large polyps throughout the stomach and two elevated lesions in the corpus and angular region, respectively (Fig. [2](#Fig2){ref-type="fig"}). Histopathological examination showed the polyps to comprise edematous lamina propria with hyperplastic foveolar epithelium and cystically dilated glands, indicating hamartomatous polyps (Fig. [3a, b](#Fig3){ref-type="fig"}). The elevated lesion in the corpus was a well-differentiated adenocarcinoma, restricted to the mucosa (Fig. [3a, c](#Fig3){ref-type="fig"}). The other elevated lesion in the angular region was a well-to-poorly differentiated adenocarcinoma invading the submucosa (Fig. [4a--c](#Fig4){ref-type="fig"}) with lymphatic permeation in the submucosa and muscularis propria detected by immunohistochemical staining with D2-40 (Fig. [4d](#Fig4){ref-type="fig"}). The carcinoma showed tubular formation in the mucosa (Fig. [4b](#Fig4){ref-type="fig"}), dedifferentiating gradually as it invaded the submucosa (Fig. [4c](#Fig4){ref-type="fig"}). Seven of 50 lymph nodes were metastasized by carcinoma cells, which was histopathologically similar to the primary tumor (no. 4d and 7). The final pathological stage was T2 N3 M0 stage IIIA. After receiving informed consent, we analyzed the patient's genomic DNA to obtain a definitive diagnosis of hamartomatous polyposis. Genomic DNA was extracted from formalin-fixed, paraffin-embedded specimens of hamartomatous polyps and carcinoma, and target genes were comprehensively analyzed by next-generation sequencing with a multiple cancer-associated gene panel. The analysis identified somatic mutations in *APC*, *KRAS*, *TP53*, and *ERBB2* genes in carcinoma, but failed to detect any germline mutations, including in *SMAD4*, *BMPR1A*, or *PTEN*, in hamartomatous polyps and carcinoma. However, based on the few characteristic physical findings and the histopathological features of the polyps, the final diagnosis was juvenile polyposis restricted to the stomach with gastric cancers. The patient was discharged on postoperative day 8 and has been monitored carefully with no adjuvant chemotherapy, by his request. There is no evidence of recurrence 16 months after surgery.Fig. 1Endoscopic appearance of multiple reddish polyps accompanied by bleeding and erosion throughout the stomach (**a**). Elevated lesions with irregular margins in the anterior wall of the corpus (**b**) and lesser curvature of the angular region (**c**) of the stomach. Biopsy of the elevated lesions revealed them to be well-differentiated adenocarcinomasFig. 2Resected specimen revealed numerous small and large polyps throughout the stomach (**a**) and two elevated lesions in the corpus and angular region (circle), respectively (**b**)Fig. 3Histopathological examination of the corpus region showed small and large polyps and one elevated lesion (**a**). The polyps comprised hyperplastic foveolar epithelium, cystically dilated glands, and edematous stroma accompanied by chronic inflammation, indicating hamartomatous polyps (**b**). The elevated lesion was diagnosed as a well-differentiated adenocarcinoma restricted to the mucosa, arising in the hamartomatous polyps (**c**). (**a** low-power view, **b** high-power view of square, × 2 objective lens; **c** high-power view of square, × 10 objective lens)Fig. 4Histopathological examination of the angular region showed the other elevated lesion (**a**). The lesion was a well-differentiated adenocarcinoma in the mucosa (**b**), becoming more poorly differentiated as it invaded the submucosa (**c**). Prominent lymphatic permeation was detected by immunohistochemical staining with D2-40 (arrow) (**d**). (**a** low-power view, **b** high-power view of square, × 2 objective lens; **c** high-power view of square, × 10 objective lens; **d** high-power view, × 10 objective lens)

Discussion {#Sec3}
==========

Juvenile polyposis is a rare disease characterized by the development of numerous hamartomatous and nonneoplastic polyps throughout the gastrointestinal tract \[[@CR1]\]. Diagnostic criteria of juvenile polyposis include the presence of more than five juvenile polyps in the colorectum, juvenile polyps throughout the gastrointestinal tract, and/or any number of juvenile polyps in a patient with a family history of juvenile polyposis \[[@CR7]\]. Juvenile polyposis was reported in 1964 as multiple hamartomatous polyps throughout the intestine, with an autosomal dominant inheritance pattern \[[@CR9]\], whereas juvenile polyposis restricted to the stomach was first reported in 1975 \[[@CR6]\]. Juvenile polyposis is currently subdivided into three groups according to occurrence site: juvenile polyposis coli, gastric juvenile polyposis, and generalized juvenile polyposis \[[@CR8], [@CR10]\].

Hamartomatous polyposis syndrome of the gastrointestinal tract with autosomal dominant inheritance includes not only juvenile polyposis, but also Peutz--Jeghers syndrome and PTEN hamartoma tumor syndrome \[[@CR11]\]. In addition, Cronkhite--Canada syndrome is a non-heritable disease that is also characterized by diffuse gastrointestinal polyps, which are histopathologically similar to hamartomatous polyps \[[@CR12], [@CR13]\]. Physical findings and family history are helpful for distinguishing between juvenile polyposis and other polyposis diseases. Patients with juvenile polyposis have few physical findings, such as cutaneous hyperpigmentation, dystrophic nail changes, and alopecia, which are detected in patients with Peutz--Jeghers or Cronkhite--Canada syndrome \[[@CR14], [@CR15]\]. In addition, patients with juvenile polyposis often show autosomal dominant inheritance, and about 75% of patients have a family history of juvenile polyposis \[[@CR1]\]. Recent investigations reported *SMAD4* \[[@CR4]\] and *BMPR1A* \[[@CR5]\] as genes responsible for juvenile polyposis. Both these genes encode proteins implicated in the transforming growth factor-β signaling pathway \[[@CR16]\], which modulates various cellular processes including proliferation, differentiation, migration, adhesion, and death \[[@CR17]\]. The prevalence of each of these germline mutations in juvenile polyposis is around 20% \[[@CR2], [@CR18]\], while the remaining patients have no such mutations. A confirmed diagnosis of juvenile polyposis is thus based not only on the histopathological features of the polyps, but also on the patient's physical findings and family history, and on the presence of germline mutations in *SMAD4* and *BMPR1A*. The current patient had no family history of juvenile polyposis or germline mutations in the *SMAD4* and *BMPR1A* genes but was diagnosed with juvenile polyposis of the stomach based on physical findings and histopathological features. Case reports of non-familial juvenile polyposis published in PubMed from 1985 to 2017, including the present case (*n* = 12), are summarized in Table [1](#Tab1){ref-type="table"} \[[@CR19]--[@CR26]\]. In contrast to the current case, most previously reported patients were relatively young (4--18 years old) and the juvenile polyposis was restricted to the colon and/or rectum, with one case of a single polyp in the stomach \[[@CR19]\]. The current case was thus a rare example of non-familial juvenile polyposis.Table 1Case reports of non-familial juvenile polyposisPatient no.YearAgeSexPresentationComplicationsExtent of involvementFindingsTreatmentNeoplasiaFollow-up after surgeryResultReference1198614FBloody diarrhea, weight loss, facial swelling--ColorectumMultiple polypsFulguration, subtotal colectomyAdenomatous features24 monthsNo recurrenceGilinsky et al. \[[@CR19]\]2198618MBloody stools, lower abdominal cramps,\
rectal prolapse, weight loss--ColonMultiple polypsPolypectomyAdenomatous features3 yearsNo recurrenceGilinsky et al. \[[@CR19]\]3198614FRectal bleeding, abdominal pain, diarrhea--Stomach\
ColorectumStomach: a single polyp\
Colon: multiple polypsStomach: polypectomy\
Colon: polypectomy, fulguration, colectomyAdenomatous features24 monthsNo recurrenceGilinsky et al. \[[@CR19]\]420007FDiarrhea, abdominal pain, abdominal lumpIntussusceptionIleo-cecumMultiple polypsRight hemicolectomyNone2 yearsNo recurrencePanchagnula and Kini \[[@CR20]\]5200115FBloody stools, rectal prolapse--ColorectumMultiple polypsProctocolectomyAdenomatous features24 monthsNo recurrenceBannura et al. \[[@CR21]\]620044FBloody stools--ColorectumMultiple polypsPolypectomyNone2 yearsDiedOkada et al. \[[@CR22]\]7200414MAbdominal pain, diarrhea--ColorectumMultiple polypsProctocolectomyAdenomatous features2 yearsNo recurrenceChakraborty et al. \[[@CR23]\]820078FRectal bleeding, syncope--ColorectumMultiple polypsTotal colectomy with rectal mucosectomyNone6 monthsNo recurrencePratap et al. \[[@CR24]\]920075FRectal bleeding, rectal prolapse--ColorectumMultiple polypsTotal colectomy with rectal mucosectomyNone6 monthsNo recurrencePratap et al. \[[@CR24]\]10200717MBloody stools, rectal prolapse--RectumMultiple polypsPolypectomyNone6 monthsNo recurrenceTony et al. \[[@CR25]\]1120178MRectal bleeding, abdominal pain, fatigability--ColonMultiple polypsTotal colectomyNone----Ahmed and Alsaleem \[[@CR26]\]12201763MAnemia, hypoalbuminemia--StomachMultiple polypsTotal gastrectomyAdenocarcinoma16 monthsNo recurrencePresent case

Although juvenile polyposis is a nonneoplastic lesion, several cases have suggested that it represents a predisposition to gastrointestinal cancer \[[@CR6]--[@CR8]\]. The risk of gastric cancer in patients with juvenile polyposis was reported to be approximately 11--21% \[[@CR27]\], with a higher risk in patients with a *SMAD4* germline mutation \[[@CR28]\]. The current patient had no germline mutations of *SMAD4* or *BMPR1A*, but did have somatic mutations in *APC*, *KRAS*, *TP53*, and *ERBB2* genes. In addition, the histopathological findings showed a well-differentiated adenocarcinoma, or intestinal type according to the Lauren classification \[[@CR29]\], directly arising in the hamartomatous polyps in the mucosa. These findings suggest that this case may be classified in the chromosomal instability group among the four molecular subtypes of gastric adenocarcinoma reported by the Cancer Genome Atlas Research Network, because this group was reported to show some salient features such as intestinal histology, *TP53* mutation, and RTK-RAS activation \[[@CR30]\].

Accordingly, patients with juvenile polyposis should undergo regular follow-ups, including gastrointestinal endoscopy, with surgical treatment in the event of gastric cancer. However, recurrences of gastric cancer and juvenile polyps in the remnant stomach have frequently been reported in patients who underwent partial gastrectomy \[[@CR31], [@CR32]\], and total gastrectomy should thus be considered in patients with juvenile polyposis of the stomach with gastric cancer.

Conclusions {#Sec4}
===========

We report a rare case of a patient with non-familial juvenile polyposis of the stomach with gastric cancers. This case highlights the malignant potential of juvenile polyposis and the need for careful follow-up of such patients. Total gastrectomy is recommended as a standard treatment in patients with juvenile polyposis of the stomach with gastric cancer.
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